Johnson Matthey Inc.
Johnson Matthey Inc. appears in FDA public data with 5 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1880-2019, Class II) was initiated on August 29, 2019.
Summary
- Total Recalls
- 5
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1880-2019 | Class II | Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nol | August 29, 2019 |
| D-1881-2019 | Class II | Cisplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Driv | August 29, 2019 |
| D-1882-2019 | Class II | Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Dr | August 29, 2019 |
| D-1252-2019 | Class III | Remifentanil HCl active pharmaceutical ingredient (API) for manufacturing, processing or repackaging | April 2, 2019 |
| D-1077-2019 | Class II | Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutic | March 5, 2018 |